DMEK vs. DSAEK: Differences and Candidacy
What Is the Difference Between DMEK and DSAEK
When the inner layer of your cornea stops working properly, a partial-thickness corneal transplant can help restore clear vision without replacing the entire cornea. DMEK (Descemet membrane endothelial keratoplasty) and DSAEK (Descemet stripping automated endothelial keratoplasty) are the two most common techniques. During DMEK surgery, only the Descemet membrane and endothelial cell layer are transplanted. This ultra-thin graft measures roughly 10 to 15 microns, making it the thinnest possible endothelial transplant. Because so little donor tissue is introduced, the cornea retains a more natural shape after healing.
In DSAEK surgery, the donor graft includes the endothelial cell layer, Descemet membrane, and a thin layer of stromal tissue. Standard grafts range from 80 to 130 microns in thickness, though ultra-thin DSAEK grafts can be prepared at less than 100 microns. The added stromal tissue makes the graft easier to handle and position during surgery, which can be an advantage in anatomically challenging eyes.
DMEK and DSAEK treat the same category of corneal conditions, specifically diseases that damage the endothelial cell layer on the back surface of the cornea. The most common indications include Fuchs endothelial dystrophy and pseudophakic bullous keratopathy. Both techniques can also address endothelial failure caused by other forms of corneal dystrophy or previous graft failure. According to the EBAA 2024 Statistical Report, endothelial keratoplasty procedures now account for the majority of corneal transplants performed in the United States.
Visual Recovery After DMEK and DSAEK
Most patients who undergo DMEK experience meaningful visual improvement within the first few weeks after surgery. Many achieve best-corrected visual acuity of 20/25 or better by three to six months, and a significant proportion reach 20/20. The thinner graft creates less optical distortion at the interface between donor and recipient tissue.
Visual recovery after DSAEK tends to be more gradual, with patients often noticing steady improvement over several months. Most patients achieve good functional vision within three to six months, though a slight hyperopic shift caused by the thicker graft may require an updated glasses prescription. Ultra-thin DSAEK grafts can narrow this recovery gap.
Several factors affect how quickly your vision improves after either procedure, including the health of your remaining corneal tissue, the degree of swelling present before surgery, and whether additional procedures such as cataract removal are performed at the same time.
Rejection Rates: DMEK vs. DSAEK
Because DMEK transplants only the Descemet membrane and endothelium, the total volume of foreign tissue introduced into the eye is minimal. Long-term studies show that DMEK carries the lowest rejection rate among all corneal transplant techniques, with approximately 10 percent of patients experiencing a suspected rejection episode within ten years.
DSAEK grafts include donor stromal tissue, which may contain antigen-presenting cells capable of triggering an immune response. Ten-year data have found suspected rejection rates near 19 percent for DSAEK. Regular follow-up visits allow our cornea specialists to detect early signs of rejection and intervene with treatment before permanent damage occurs.
Common symptoms of rejection include increasing redness, light sensitivity, blurred vision, and eye discomfort that develops weeks to months after surgery. If caught early, most rejection episodes can be treated successfully with intensive anti-inflammatory eye drops.
Who Is a Better Candidate for DMEK vs. DSAEK
DMEK tends to work best in eyes with relatively straightforward anatomy. Good candidates typically have Fuchs endothelial dystrophy or uncomplicated bullous keratopathy with a natural crystalline lens or posterior chamber intraocular lens in place, an intact iris without large defects, no history of glaucoma drainage device surgery, and adequate anterior chamber depth.
DSAEK is often preferred when the eye presents added complexity that makes handling and positioning a thin DMEK graft more difficult. Situations that may favor DSAEK include previous glaucoma surgery with tube shunts or trabeculectomy, aphakia or an anterior chamber intraocular lens, aniridia or significant iris defects, advanced corneal edema with poor visibility, prior corneal transplant requiring regrafting, and history of vitreoretinal surgery.
Many patients with endothelial dysfunction also have cataracts. Both DMEK and DSAEK can be performed at the same time as cataract surgery, known as a triple procedure. Combining surgeries reduces the total number of operations, shortens overall recovery time, and allows the new lens implant to be selected with your corneal healing in mind.
Frequently Asked Questions
DSAEK generally has a lower overall complication rate than DMEK. The most notable difference is in rebubbling, a secondary procedure to reattach the graft if it partially detaches after surgery. DMEK rebubbling rates range from roughly 20 to 34 percent in published studies, while DSAEK rebubbling rates typically fall between 4 and 11 percent.
DMEK generally produces slightly better best-corrected visual acuity, with a higher proportion of patients reaching 20/20 at one year. Studies using ultra-thin DSAEK grafts under 70 microns have found that the visual acuity gap between the two procedures narrows significantly.
Both DMEK and DSAEK can be repeated if the original graft fails over time. Performing a second endothelial keratoplasty after a previous graft is more technically challenging than a primary surgery regardless of which technique was used initially.
Yes. If a DSAEK graft eventually fails or if visual results are not satisfactory, the DSAEK tissue can be removed and replaced with a DMEK graft. This conversion is a recognized approach and can produce improved visual outcomes for some patients.
The decision comes down to a combination of your eye anatomy, surgical history, visual goals, and the specific condition causing your endothelial dysfunction. For patients with uncomplicated Fuchs dystrophy and normal eye anatomy, DMEK is often the preferred choice. For patients with complex eyes or prior surgeries, DSAEK remains a reliable and effective alternative.
What our Patients say
4.8
Reviews
(3,408)